Loading clinical trials...
Loading clinical trials...
Study of Prognostic Value of T Cell Receptor Diversity and CD4 Lymphopenia in First Relapse Breast or Lung Cancer Patients
Conditions
Interventions
Breast cancer cohort
Lung cancer cohort
Locations
4
France
Hopital de la Croix Rousse
Lyon, France
Centre Léon Bérard
Lyon, France
Hopital Privé Jean Mermoz
Lyon, France
CHLS
Pierre-Bénite, France
Start Date
July 1, 2010
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
July 2, 2015
NCT07336732
NCT07485114
NCT06066138
NCT07486219
NCT04704661
NCT07190248
Lead Sponsor
Centre Leon Berard
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions